Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Clin Respir J ; 14(6): 533-540, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32043808

RESUMEN

PURPOSE: We investigated the effectiveness, safety and compliance of Zheng's Supine Rehabilitation Exercise (ZSRE) as a rehabilitation programme among elderly patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). PATIENTS AND METHODS: About 82 elderly patients with AECOPD were divided into a rehabilitation group and control group on their admission day, and both groups received routine medical treatment. Patients in the rehabilitation group started ZSRE on the second day of admission and continued until 8 weeks after discharge. RESULTS: At the 9th week after discharge, the COPD Assessment Test (CAT), 6-minute walking distance (6MWD) and Modified Medical Research Council Dyspnea Scale (mMRC) in the rehabilitation group were all significantly better than those in the control group (P < 0.01; P < 0.01; and P < 0.05, respectively). In the rehabilitation group, the CAT and 6MWD were significantly improved in the 9th week after discharge as compared with those at admission or discharge, and mMRC was significantly improved at the 9th week after discharge as compared with that at admission (all P < 0.01). CONCLUSION: ZSRE can be performed by elderly patients with the acute exacerbation of severe or extremely severe COPD with high safety and compliance and was helpful for their recovery.


Asunto(s)
Terapia por Ejercicio/métodos , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Enfermedad Pulmonar Obstructiva Crónica/rehabilitación , Posición Supina/fisiología , Anciano , Estudios de Casos y Controles , Progresión de la Enfermedad , Hospitalización/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Cooperación del Paciente/estadística & datos numéricos , Recuperación de la Función/fisiología , Pruebas de Función Respiratoria/métodos , Pruebas de Función Respiratoria/estadística & datos numéricos , Seguridad , Resultado del Tratamiento , Prueba de Paso/métodos , Prueba de Paso/estadística & datos numéricos
2.
J Ethnopharmacol ; 137(1): 414-20, 2011 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-21669272

RESUMEN

This study was designed to investigate the effects of the Chinese Yi-Qi-Bu-Shen Recipe (YB) on brain stem auditory evoked potential (BAEP) in diabetic rats and on the protection of the diabetic rat brain's functional lesion. Thirty-three male rats were randomly divided into three groups: the normal control group (NC), the diabetic group (DM), and the diabetic rats treated with YB group (DM+YB). Blood glucose and body weight were measured every three weeks. After six weeks, the serum insulin, blood biochemical indices, superoxide dismutase, malondialdehyde, monoamine neurotransmitters, and BAEP were measured. Compared with the NC group, the waves III, V PLs, and the I-III, I-V IPLs of BAEP in the DM group were significantly delayed (all P<0.05). However, YB-treated diabetic rats maintained a normal brainstem function over the experimental period. Compared with the NC group, the waves I, III, V PL, and waves I-III, III-V and I-V IPLs of BAEP in the DM+YB group were very close (all P>0.05). On the other hand, compared with the DM group, the III, V PLs and the I-III, I-V IPLs of BAEP in the DM+YB group were significantly improved. It was discovered that the central conduction time of rats with diabetes had a close correlation with serum insulin, blood glucose, malondialdehyde, and insulin resistance index. Our results suggest that YB extract has a beneficial effect in preserving the brain's electrophysiological function in diabetic rats, likely through its antihyperglycemic activity, ability to reduce insulin resistance, and antioxidant activity.


Asunto(s)
Tronco Encefálico/efectos de los fármacos , Diabetes Mellitus Experimental/tratamiento farmacológico , Medicamentos Herbarios Chinos/farmacología , Potenciales Evocados Auditivos del Tronco Encefálico/efectos de los fármacos , Hipoglucemiantes/farmacología , Fármacos Neuroprotectores/farmacología , Estimulación Acústica , Animales , Monoaminas Biogénicas/metabolismo , Glucemia/efectos de los fármacos , Glucemia/metabolismo , Peso Corporal , Tronco Encefálico/metabolismo , Tronco Encefálico/fisiopatología , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/fisiopatología , Insulina/sangre , Resistencia a la Insulina , Masculino , Malondialdehído/sangre , Conducción Nerviosa/efectos de los fármacos , Ratas , Ratas Wistar , Superóxido Dismutasa/sangre
3.
Zhong Yao Cai ; 34(9): 1392-5, 2011 Sep.
Artículo en Chino | MEDLINE | ID: mdl-22260008

RESUMEN

OBJECTIVE: To establish a HPLC method for measuring tashinone II(A) concentration in rabbit plasma and study the pharmacokinetics of tashinone II(A) -loaded polylactic acid nanoparticles and tashinone II(A) injection in rabbits. METHODS: A single dose of TS-PLA-NP and TS II(A) injection was administered to 8 healthy rabbits via the ear-edge vein, at the set time withdrew the blood and prepared. The concentrations of tashinone II(A) in plasma were measured by HPLC with gemfibrozil as the internal standard. The pharmacokinetic parameters of TS-PLA-NP and tashinone II(A) injection were calculated by program DAS2.0. RESULTS: The average retention times of gemfibrozil and tashinone II(A) were 10.5 and 14.5 min, respectively. The half-life was prolonged from 2. 573 h of free tashinone II(A) to 4. 117 h and MRT(0-infinity) from 2.585 h to 6.033 h. The max concentration of tashinone II(A) was reduced from 0.21 to 0.134 mg/L. CONCLUSION: The method for the pharmacokinetic research of tshinone II A in rabbit plasma is accuracy, rapid and sensitive. TS-PLA-NP shows significant characteristic of delayed-release.


Asunto(s)
Abietanos/farmacocinética , Antineoplásicos/farmacocinética , Carcinoma Hepatocelular/patología , Hígado/metabolismo , Nanopartículas/química , Polímeros/química , Abietanos/administración & dosificación , Abietanos/farmacología , Animales , Antineoplásicos/administración & dosificación , Antineoplásicos/farmacología , Área Bajo la Curva , Carcinoma Hepatocelular/metabolismo , Línea Celular Tumoral , Cromatografía Líquida de Alta Presión , Preparaciones de Acción Retardada , Sistemas de Liberación de Medicamentos , Inyecciones Intravenosas , Nanopartículas/administración & dosificación , Trasplante de Neoplasias , Tamaño de la Partícula , Polímeros/administración & dosificación , Conejos , Factores de Tiempo , Distribución Tisular
4.
Chinese Medical Journal ; (24): 1673-1678, 2010.
Artículo en Inglés | WPRIM (Pacífico Occidental) | ID: wpr-241740

RESUMEN

<p><b>BACKGROUND</b>The prevalence and the spectrum of thyroid dysfunction in the mainland of China are not adequately understood. We performed a population-based study to determine the prevalence of major thyroid dysfunctions including overt and subclinical hyper- and hypothyroidism in a stable cohort.</p><p><b>METHODS</b>All active and retired employees aged 20 years and older (11 067) of Sinopec Zhenhai Refining & Chemical Company in Ningbo participated in the cross-sectional survey with a questionnaire and blood samples.</p><p><b>RESULTS</b>A total of 10 405 individuals attended for screening. Using biochemical definitions 95.5% were euthyroid. The prevalence of former diagnosed hyperthyroidism was 1.1% in females and 0.4% in males, hypothyroidism 1.7% and 0.3%, and thyroid surgery 1.2% and 0.3%, respectively. In both sex the prevalence increased with age. Twenty-four percent of individuals with thyroid surgery or medications had abnormal thyroid-stimulating hormone (TSH) levels. In individuals without a history of thyroid disease, the prevalence of pathological TSH values in females and males were TSH > or = 10 mU/L 0.60% and 0.29%; TSH 4.8-9.9 mU/L 5.71% and 2.25%; TSH < 0.3 mU/L 0.87% and 0.41%, respectively. Overt hyper- and hypothyroidism were uncommon (0.2%, 0.3%, respectively). The prevalence of subclinical hyper- and hypothyroidism was 0.4% and 3.4%, respectively. Subclinical hypothyroidism was more common in females (male 2.4% vs. female 5.8%, P < 0.001) and with increasing age (P < 0.001).</p><p><b>CONCLUSIONS</b>The prevalence of thyroid dysfunction is 4.5% in the cohort. Among individuals with thyroid medications or surgery, only 75.7% were within the normal range of TSH. These results indicate that thyroid dysfunction is common in Chinese adults.</p>


Asunto(s)
Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Estudios Transversales , Hipertiroidismo , Epidemiología , Metabolismo , Hipotiroidismo , Epidemiología , Metabolismo , Encuestas y Cuestionarios , Enfermedades de la Tiroides , Epidemiología , Metabolismo , Pruebas de Función de la Tiroides , Tirotropina , Metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...